Gastric emptying of non-disintegrating solid drug delivery systems in fasted state: relevance to drug dissolution

Bibliography

• Dressman JB, Vertzoni M, Goumas K, Reppas C. Estimating drug solubility in the gastrointestinal tract. Adv Drug Deliv Rev 2007;59(7):591-602
   PubMed Web of Science ®Google Scholar
• Avdeef A. Solubility of sparingly-soluble ionizable drugs. Adv Drug Deliv Rev 2007;59(7):568-90
   PubMed Web of Science ®Google Scholar
• United States Pharmacopeial Convention. The United States Pharmacopoeia; USP 32-NF 27. Rockville, MD, USA, 2008
   Google Scholar
• Kimura T, Higaki K. Gastrointestinal transit and drug absorption. Biol Pharm Bull 2002;25(2):149-64
   PubMed Web of Science ®Google Scholar
• Wilding IR, Coupe AJ, Davis SS. The role of gamma-scintigraphy in oral drug delivery. Adv Drug Deliv Rev 2001;46(1-3):103-24
   PubMed Web of Science ®Google Scholar
• Weitschies W, Blume H, Monnikes H. Magnetic marker monitoring: high resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract. Eur J Pharm Biopharm 2010;74(1):93-101
   PubMed Web of Science ®Google Scholar
• Weitschies W, Kosch O, Monnikes H, Trahms L. Magnetic Marker Monitoring: an application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. Adv Drug Deliv Rev 2005;57(8):1210-22
   PubMed Web of Science ®Google Scholar
• Weitschies W, Wedemeyer J, Stehr R, Trahms L. Magnetic markers as a noninvasive tool to monitor gastrointestinal transit. IEEE Trans Biomed Eng 1994;41(2):192-5
   PubMed Web of Science ®Google Scholar
• Minami H, McCallum RW. The physiology and pathophysiology of gastric emptying in humans. Gastroenterology 1984;86(6):1592-610
   PubMed Web of Science ®Google Scholar
• Weitschies W, Friedrich C, Wedemeyer RS, Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying. Eur J Pharm Biopharm 2008;70(2):641-8
   PubMed Web of Science ®Google Scholar
• Davis SS, Hardy JG, Taylor MJ, The effect of food on the gastrointestinal transit of pellets and an osmotic device (Osmet). Int J Pharm 1984;21(3):331-40
   Web of Science ®Google Scholar
• Wilding IR, Sparrow RA, Davis SS, Horton RJ. The role of gastric-emptying in the absorption and metabolism of nifedipine given in a modified release pellet formulation. Int J Pharm 1992;84(1):59-67
   Web of Science ®Google Scholar
• Moes AJ. Gastroretentive dosage forms. Crit Rev Ther Drug Carrier Syst 1993;10(2):143-95
   PubMed Web of Science ®Google Scholar
• Wilding I. Site-specific drug delivery in the gastrointestinal tract. Crit Rev Ther Drug Carrier Syst 2000;17(6):557-620
   PubMed Web of Science ®Google Scholar
• Talukder R, Fassihi R. Gastroretentive delivery systems: a mini review. Drug Dev Ind Pharm 2004;30(10):1019-28
   PubMed Web of Science ®Google Scholar
• Streubel A, Siepmann J, Bodmeier R. Gastroretentive drug delivery systems. Expert Opin Drug Deliv 2006;3(2):217-33
   PubMedGoogle Scholar
• Clarke GM, Newton JM, Short MD. Gastrointestinal transit of pellets of differing size and density. Int J Pharm 1993;100(1-3):81-92
   Web of Science ®Google Scholar
• Clarke GM, Newton JM, Short MB. Comparative gastrointestinal transit of pellet systems of varying density. Int J Pharm 1995;114(1):1-11
   Web of Science ®Google Scholar
• Locatelli I, Mrhar A, Bogataj M. Gastric emptying of pellets under fasting conditions: a mathematical model. Pharm Res 2009;26(7):1607-17
   PubMed Web of Science ®Google Scholar
• Podczeck F, Newton JM, Yuen KH. The description of the gastrointestinal transit of pellets assessed by gamma scintigraphy using statistical moments. Pharm Res 1995;12(3):376-9
   PubMed Web of Science ®Google Scholar
• Hunter E, Fell JT, Sharma H. The gastric emptying of pellets contained in hard gelatin capsules. Drug Dev Ind Pharm 1982;8(5):751-7
   Web of Science ®Google Scholar
• Yuen KH, Deshmukh AA, Newton JM, Gastrointestinal transit and absorption of theophylline from a multiparticulate controlled-release formulation. Int J Pharm 1993;97(1-3):61-77
   Web of Science ®Google Scholar
• Christensen FN, Davis SS, Hardy JG, The Use of gamma-scintigraphy to follow the gastrointestinal transit of pharmaceutical formulations. J Pharm Pharmacol 1985;37(2):91-5
   PubMed Web of Science ®Google Scholar
• Davis SS, Hardy JG, Fara JW. Transit of pharmaceutical dosage forms through the small intestine. Gut 1986;27(8):886-92
   PubMed Web of Science ®Google Scholar
• Devereux JE, Newton JM, Short MB. The influence of density on the gastrointestinal transit of pellets. J Pharm Pharmacol 1990;42(7):500-1
   PubMed Web of Science ®Google Scholar
• Wilding IR, Kenyon CJ, Hooper G. Gastrointestinal spread of oral prolonged-release mesalazine microgranules (Pentasa) dosed as either tablets or sachet. Aliment Pharmacol Ther 2000;14(2):163-9
   PubMed Web of Science ®Google Scholar
• Khosla R, Davis SS. The gastric emptying of pellets in supine volunteers. J Pharm Pharmacol 1986;38:P10
   Google Scholar
• Hardy JG, Perkins AC. Validity of the geometric mean correction in the quantification of whole bowel transit. Nucl Med Commun 1985;6(4):217-24
   PubMed Web of Science ®Google Scholar
• Hardy JG, Wilson CG, Wood E. Drug delivery to the proximal colon. J Pharm Pharmacol 1985;37(12):874-7
   PubMed Web of Science ®Google Scholar
• Khosla R, Davis SS. The effect of polycarbophil on the gastric emptying of pellets. J Pharm Pharmacol 1987;39(1):47-9
   PubMed Web of Science ®Google Scholar
• Wilding IR, Hardy JG, Maccari M, Scintigraphic and pharmacokinetic assessment of a multiparticulate sustained-release formulation of diltiazem. Int J Pharm 1991;76(1-2):133-43
   Web of Science ®Google Scholar
• Basit AW, Newton JM, Short MD, The effect of polyethylene glycol 400 on gastrointestinal transit: implications for the formulation of poorly-water soluble drugs. Pharm Res 2001;18(8):1146-50
   PubMed Web of Science ®Google Scholar
• Basit AW, Podczeck F, Newton JM, The use of formulation technology to assess regional gastrointestinal drug absorption in humans. Eur J Pharm Sci 2004;21(2-3):179-89
   PubMed Web of Science ®Google Scholar
• Elashoff JD, Reedy TJ, Meyer JH. Analysis of gastric emptying data. Gastroenterology 1982;83(6):1306-12
   PubMed Web of Science ®Google Scholar
• Podczeck F, Course NJ, Newton JM. Determination of the gastric emptying of solid dosage forms using gamma-scintigraphy: a problem of image timing and mathematical analysis. Eur J Nucl Med 1999;26(4):373-8
   PubMedGoogle Scholar
• Kaus LC, Fell JT, Sharma H, Taylor DC. On the intestinal transit of a single non-disintegrating object. Int J Pharm 1984;20(3):315-23
   Web of Science ®Google Scholar
• Sangekar S, Vadino WA, Chaudry I, Evaluation of the effect of food and specific gravity of tablets on gastric retention time. Int J Pharm 1987;35(3):187-91
   Web of Science ®Google Scholar
• Davis SS, Stockwell AF, Taylor MJ, The effect of density on the gastric emptying of single-unit and multiple-unit dosage forms. Pharm Res 1986;3(4):208-13
   PubMed Web of Science ®Google Scholar
• Podczeck F, Course NC, Newton JM, Short MB. The influence of non-disintegrating tablet dimensions and density on their gastric emptying in fasted volunteers. J Pharm Pharmacol 2007;59(1):23-7
   PubMed Web of Science ®Google Scholar
• Park HM, Chernish SM, Rosenek BD, Gastric emptying of enteric-coated tablets. Digest Dis Sci 1984;29(3):207-12
   PubMed Web of Science ®Google Scholar
• Davis SS, Hardy JG, Wilson CG, Gastrointestinal transit of a controlled release naproxen tablet formulation. Int J Pharm 1986;32(1):85-90
   Web of Science ®Google Scholar
• Adkin DA, Davis SS, Sparrow RA, Wilding IR. Colonic transit of different sized tablets in healthy subjects. J Control Release 1993;23(2):147-56
   Web of Science ®Google Scholar
• Sugito K, Ogata H, Goto H, Gastrointestinal transit of nondisintegrating solid formulations in humans. Int J Pharm 1990;60(2):89-97
   Web of Science ®Google Scholar
• Khosla R, Davis SS. Gastric emptying and small and large bowel transit of non-disintegrating tablets in fasted subjects. Int J Pharm 1989;52(1):1-10
   Web of Science ®Google Scholar
• Wilding IR, Davis SS, Sparrow RA, Pharmacoscintigraphic evaluation of a modified release (Geomatrix®) diltiazem formulation. J Control Release 1995;33(1):89-97
   Web of Science ®Google Scholar
• Locatelli I, Rostohar V, Voinovich D, Evaluation of dissolution profiles by the aid of a model of gastric emptying of tablets under fasting conditions. Conference abstract. Farm Vest, (Pharm J Slovenia) 2008;59:185-6. Available from: http://www.sfd.si/modules/catalog/products/prodfile/fv_posebna_stevilka.pdf
   Google Scholar
• Jamei M, Turner D, Yang J, Population-based mechanistic prediction of oral drug absorption. AAPS J 2009;11(2):225-37
   PubMed Web of Science ®Google Scholar
• Podczeck F, Course N, Newton JM, Short MB. Gastrointestinal transit of model mini-tablet controlled release oral dosage forms in fasted human volunteers. J Pharm Pharmacol 2007;59(7):941-5
   PubMed Web of Science ®Google Scholar
• Damle B, Ullah I, Doll W, Pharmacokinetics and gamma scintigraphy evaluation of two enteric coated formulations of didanosine in healthy volunteers. Brit J Clin Pharmacol 2002;54(3):255-61
   PubMed Web of Science ®Google Scholar
• Davis SS, Hardy JG, Taylor MJ, A Comparative study of the gastrointestinal transit of a pellet and tablet formulation. Int J Pharm 1984;21(2):167-77
   Web of Science ®Google Scholar
• Brunner M, Greinwald R, Kletter K, Gastrointestinal transit and release of 5-aminosalicylic acid from Sm-153-labelled mesalazine pellets vs. tablets in male healthy volunteers. Aliment Pharmacol Ther 2003;17(9):1163-9
   PubMed Web of Science ®Google Scholar
• Schiller C, Frohlich CP, Giessmann T, Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment Pharmacol Ther 2005;22(10):971-9
   PubMed Web of Science ®Google Scholar
• Garbacz G, Wedemeyer RS, Nagel S, Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses. Eur J Pharm Biopharm 2008;70(2):421-8
   PubMed Web of Science ®Google Scholar